Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models

Journal of Neurosurgery

Volumn 118, Issue 4, 2013, Pages 838-845

  Watanabe, Takashi ^a   Ohtani, Toshiyuki ^b   Aihara, Masanori ^c   Ishiuchi, Shogo ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TAKASAKI GENERAL MEDICAL CENTER   (Japan)

^c MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Akt; AMPAR; Glioblastoma; Oncology; Platelet derived growth factor receptor; Xenograft model

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; STEM CELL FACTOR; VIMENTIN; ZONAMPANEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLIOBLASTOMA; HUMANS; IMIDAZOLES; MICE; MICE, NUDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; TYRPHOSTINS;

EID: 84875863362     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.11.JNS12362     Document Type: Article

References (41)

1. Alessi DR, Cohen P: Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8:55-62, 1998
2. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843-7848, 2006
3. Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, et al: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52:3498-3502, 1992
4. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 411:355-365, 2001
5. Brewer GJ, Torricelli JR: Isolation and culture of adult neurons and neurospheres. Nat Protoc 2:1490-1498, 2007
6. Carmeliet P: Angiogenesis in health and disease. Nat Med 9: 653-660, 2003
7. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, et al: Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742-2746, 2003
8. Cully M, You H, Levine AJ, Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184-192, 2006
9. Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13:2905-2927, 1999
10. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241, 1997
11. de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK: Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol 88:121-133, 2008
12. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al: Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408-2417, 2006
13. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037, 2001
14. Engelman JA, Luo J, Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619, 2006
15. Gilbertson RJ, Rich JN: Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7:733-736, 2007
16. Grossman SA, Ye X, Chamberlain M, Mikkelsen T, Batchelor T, Desideri S, et al: Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J Clin Oncol 27:4155-4161, 2009
17. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD: Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60:168-173, 1995
18. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, et al: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219, 1992
19. Holland EC: Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2:120-129, 2001
20. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55-57, 2000
21. Howes JF, Bell C: Talampanel. Neurotherapeutics 4:126-129, 2007
22. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, et al: Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978, 2002
23. Ishiuchi S, Yoshida Y, Sugawara K, Aihara M, Ohtani T, Watanabe T, et al: Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:7987-8001, 2007
24. Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN: Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207:224-231, 2005
25. Kovalenko M, Gazit A, Böhmer A, Rorsman C, Rönnstrand L, Heldin CH, et al: Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6106-6114, 1994
26. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372, 1996
27. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA: Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62:3729-3735, 2002
28. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378, 1998
29. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, et al: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333, 2001
30. Raymond E, Brandes AA, Dittrich C, Fumoleau P, Coudert B, Clement PM, et al: Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study. J Clin Oncol 26:4659-4665, 2008
31. Savage DG, Antman KH: Imatinib mesylate - a new oral targeted therapy. N Engl J Med 346:683-693, 2002
32. Shimizu-Sasamata M, Kano T, Rogowska J, Wolf GL, Moskowitz MA, Lo EH: YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats. Stroke 29:2141-2148, 1998
33. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, et al: Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318:287-290, 2007
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
35. Suzuki Y, Shirai K, Oka K, Mobaraki A, Yoshida Y, Noda SE, et al: Higher pAkt expression predicts a significant worse prognosis in glioblastomas. J Radiat Res (Tokyo) 51:343-348, 2010
36. Weidner N: Tumour vascularity and proliferation: clear evidence of a close relationship. J Pathol 189:297-299, 1999
37. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119-122, 1998
38. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 359:492-507, 2008
39. Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, et al: Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res 12:4899-4907, 2006
40. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, et al: The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448, 2000
41. Yoshida Y, Tsuzuki K, Ishiuchi S, Ozawa S: Serum-dependence of AMPA receptor-mediated proliferation in glioma cells. Pathol Int 56:262-271, 2006